Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

NCT01879722 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda